Table 3.
Magnetic resonance imaging (MRI) features of 15 patients with inflammatory breast cancer (IBC) and 12 patients with non-inflammatory breast cancer
| Parameters | IBC |
cT2 breast cancer |
||||
|---|---|---|---|---|---|---|
| Vstart | Vend | Vend-Vstart* | Vstart | Vend | Vend-Vstart* | |
| RECIST | 84.8 | 45.6 | 0.54 | 26.8 | 14.8 | 0.55 |
| Lesion size, mm | ||||||
| Cranial-caudal (CC) | 64.3 | 33.9 | 0.53 | 23.7 | 10.3 | 0.43 |
| Anterior-posterior (AP) | 76.1 | 34.3 | 0.45 | 24.5 | 12.8 | 0.52 |
| Left-right (LR) | 61.7 | 32.5 | 0.53 | 22.8 | 11.9 | 0.52 |
| Number of vessels | 4.1 | 3.3 | 0.80 | 2.3 | 1.4 | 0.61 |
| Peak enhancement (100% threshold) | 352.3 | 252.6 | 0.72 | 316.7 | 147.3 | 0.47 |
| Volume (CC 100%) | 67.0 | 18.6 | 0.28 | 5.1 | 0.2 | 0.04 |
| Volume (CC 40%) | 140.3 | 72.1 | 0.51 | 8.0 | 1.3 | 0.16 |
| 100% curve distribution | ||||||
| 1 | 41.4 | 63.8 | 1.54 | 31.8 | 55.0 | 1.73 |
| 2 | 50.6 | 33.5 | 0.66 | 57.8 | 36.2 | 0.63 |
| 3 | 8.0 | 2.7 | 0.34 | 10.3 | 8.8 | 0.85 |
| 40% curve distribution | ||||||
| 1 | 56.2 | 76.2 | 1.36 | 49.0 | 72.0 | 1.47 |
| 2 | 38.0 | 21.2 | 0.56 | 42.8 | 20.5 | 0.48 |
| 3 | 5.9 | 2.4 | 0.41 | 8.1 | 7.6 | 0.94 |
*
Percentage of change, Vend (MRI parameters after neoadjuvant chemotherapy) relative to Vstart (MRI parameters prior to neoadjuvant chemotherapy).